Zyla Health has announced a successful funding round of $4 million in its Series A, with Exfinity Venture Partners taking the lead in the investment drive. Notably, this funding initiative saw the active participation of notable investors such as Sony Innovation Fund, Venture Catalysts, and Aureolis, led by Paula Mariwala.
The Gurugram based Zyla Health will deploy the fresh capital to expedite its growth across three pivotal sectors—insurance, corporates, and big pharma. The company intends to channel these funds into strategic product integrations within the healthcare ecosystem, aiming for a significant expansion in scale and outreach.
Khushboo Aggarwal, Founder and CEO of Zyla Health, voiced her enthusiasm about the company’s trajectory, emphasizing, “It is a very exciting time at Zyla; we have witnessed 300% year-on-year growth and 100% retention of our key B2B accounts in the last one year. With a fantastic leadership team by our side and the new fuel for growth, we are ready to truly revolutionize healthcare delivery in India.”
This recent funding milestone comes after Zyla Health’s securing of $1 million during its pre-Series A round in July of the previous year. The earlier funding round was spearheaded by a group of angel investors, including Kae Capital, Secocha Ventures, Canara Bank Ventures, and Seeders, among other institutional supporters.
Zyla Health operates as a care management platform, providing personalized care for chronic patients through its in-house care team. The platform’s strength lies in its seamless integration within the healthcare ecosystem via APIs, establishing connections across client data lakes, diagnostic vendors, and smart devices, thereby enhancing scalability and accessibility.
The company boasts an impressive client portfolio that encompasses Max Life Insurance, HDFC Ergo, Pfizer, Zydus, IBM, DHL, Godrej, GEP, and several others. Zyla Health’s objective revolves around improving the health conditions of high-risk individuals, ultimately leading to reduced insurance claims, decreased insurance premiums for corporates, and enhanced medication outcomes for pharmaceutical drug users.
The successful completion of this Series A funding positions Zyla Health strategically for its ambitious plans of disrupting and innovating healthcare delivery in India, focusing on comprehensive solutions for diverse healthcare stakeholders.
